ES2078356T3 - Derivados de la pirrolidina y de la piperidina. - Google Patents
Derivados de la pirrolidina y de la piperidina.Info
- Publication number
- ES2078356T3 ES2078356T3 ES90917305T ES90917305T ES2078356T3 ES 2078356 T3 ES2078356 T3 ES 2078356T3 ES 90917305 T ES90917305 T ES 90917305T ES 90917305 T ES90917305 T ES 90917305T ES 2078356 T3 ES2078356 T3 ES 2078356T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- pct
- formula
- group
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SEGUN LA INVENCION SE FACILITA UN COMPUESTO CON LA FORMULA (I) : R1-O(CH2)MA(CH2)NXR O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, EN DONDE R1 ES UN GRUPO CON LA FORMULA (A O B) EN DONDE Z ES -(CH2)2-, -CH = CH-, -CH2-SPO CON LA FORMULA (C, D O HET) Y A ES UN GRUPO CON LA FORMULA (E, F O G)$0 EN EL QUE EL ATOMO DE N ESTA UNIDO AL GRUPO (CH2)N; M ES 1 O 2; N ES UN ENTERO DE DE 1 A 4; P ES 1, 2 O 3; R2 Y R3 SON CADA UNO INDEPENDIENTEMENTE HIDROGENO, C1-C4 ALQUILO, HIDROXI-(C1-C4 ALQUILO), HIDROXI, C1-C4 ALCOXI, HALO, TRIFLUOROMETILO, NITRO, CIANO, SULFAMOILO, -CO(C1-C4 ALQUILO), -OCO(C1-C4 ALQUILO), CARBOXI, -CO2(C1-C4 ALQUILO), -(CH2)QCONR4R5, -(CH2)QOCONR4R5, (CH2)QNR6R7 O -NHSO2NH2 EN DONDE R4 Y R5 SON CADA UNO INDEPENDIENTEMENTE H O C1-C4 ALQUILO, Q ES 0, 1 O 2 Y R6 Y R7 SON CADA UNO INDEPENDIENTEMENTE H O C1-C4 ALQUILO O R6 ES HIDROGENO Y R7 ES -SO2(C1-C4 ALQUILO), -CO(C1-C4 ALQUILO) O -CONH(C1-C4 ALQUILO); X ES UN ENLACE DIRECTO, O O S; Y E Y'' SON CADA UNO INDEPENDIENTEMENTE O O CH2; Y HET ES PIRIDILO, PIRACINILO O TIENILO. LOS COMPUESTOS SON UTILES COMO ANTAGONISTAS RECEPTORES MUSCARINICOS, PARTICULARMENTE EN EL TRATAMIENTO DEL SINDROME DE INTESTINO IRRITABLE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909000301A GB9000301D0 (en) | 1990-01-06 | 1990-01-06 | Piperidine & pyrrolidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2078356T3 true ES2078356T3 (es) | 1995-12-16 |
Family
ID=10668922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90917305T Expired - Lifetime ES2078356T3 (es) | 1990-01-06 | 1990-11-28 | Derivados de la pirrolidina y de la piperidina. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5344835A (es) |
EP (1) | EP0510003B1 (es) |
JP (1) | JPH0692365B2 (es) |
AT (1) | ATE128463T1 (es) |
CA (1) | CA2067758C (es) |
DE (1) | DE69022744T2 (es) |
DK (1) | DK0510003T3 (es) |
ES (1) | ES2078356T3 (es) |
FI (1) | FI922341A (es) |
GB (1) | GB9000301D0 (es) |
GR (1) | GR3017944T3 (es) |
IE (1) | IE69312B1 (es) |
PT (1) | PT96421B (es) |
WO (1) | WO1991010650A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
GB9020051D0 (en) * | 1990-09-13 | 1990-10-24 | Pfizer Ltd | Muscarinic receptor antagonists |
US5859295A (en) * | 1994-12-05 | 1999-01-12 | University Of Kentucky Research Foundation | Canavanine analogs and their use as chemotherapeutic agents |
US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
BR9908351A (pt) * | 1998-02-04 | 2001-11-20 | Banyu Pharma Co Ltd | Compostos, processo para a preparação dosmesmos, e, composição farmacêutica |
US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
CA2369588C (en) * | 1999-04-07 | 2011-02-08 | Lloyd S. Gray | Anticancer calcium channel blockers |
US8211916B2 (en) * | 2000-06-20 | 2012-07-03 | Wayne State University | N- and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating CNS disorders therewith |
AU2001275537A1 (en) * | 2000-06-20 | 2002-01-02 | Wayne State University | N-and o-substituted 4-(2-(diphenylmethoxy)-ethyl)-1-((phenyl)methyl)piperidine analogs and methods of treating cns disorders therewith |
TWI295669B (en) * | 2002-10-30 | 2008-04-11 | Theravance Inc | Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds |
US8017791B2 (en) * | 2003-03-28 | 2011-09-13 | Wayne State University | Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel, 3,6-disubstituted pyran derivatives |
TW200510298A (en) * | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
WO2005007645A1 (en) * | 2003-07-11 | 2005-01-27 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
US7250414B2 (en) * | 2004-03-11 | 2007-07-31 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
EP1725525A1 (en) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
CA2563161C (en) | 2004-04-16 | 2017-01-24 | Wayne State University | Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3, 6-disubstituted pyran derivatives |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE934890C (de) * | 1951-10-07 | 1955-11-10 | Chem Fab Promonta Ges Mit Besc | Verfahren zur Herstellung von basischen Benzhydrylaethern |
GB780027A (en) * | 1955-01-20 | 1957-07-31 | Schering Corp | 3-piperidyl ethers and thioethers |
US2974146A (en) * | 1956-02-24 | 1961-03-07 | Lakeside Lab Inc | 3-piperidyl benzhydryl ethers |
US4810713A (en) * | 1985-12-20 | 1989-03-07 | A. H. Robins Company, Incorporated | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment |
EP0235463A3 (en) * | 1985-12-20 | 1990-01-17 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents |
GB8816365D0 (en) * | 1988-07-08 | 1988-08-10 | Pfizer Ltd | Therapeutic agents |
ATE169616T1 (de) * | 1988-11-21 | 1998-08-15 | Zeneca Ltd | Zwischenverbindungen zur herstellung von fungiziden |
-
1990
- 1990-01-06 GB GB909000301A patent/GB9000301D0/en active Pending
- 1990-11-28 CA CA002067758A patent/CA2067758C/en not_active Expired - Fee Related
- 1990-11-28 JP JP3500113A patent/JPH0692365B2/ja not_active Expired - Fee Related
- 1990-11-28 AT AT90917305T patent/ATE128463T1/de not_active IP Right Cessation
- 1990-11-28 US US07/890,595 patent/US5344835A/en not_active Expired - Fee Related
- 1990-11-28 DE DE69022744T patent/DE69022744T2/de not_active Expired - Fee Related
- 1990-11-28 WO PCT/EP1990/002039 patent/WO1991010650A1/en active IP Right Grant
- 1990-11-28 EP EP90917305A patent/EP0510003B1/en not_active Expired - Lifetime
- 1990-11-28 ES ES90917305T patent/ES2078356T3/es not_active Expired - Lifetime
- 1990-11-28 DK DK90917305.6T patent/DK0510003T3/da active
-
1991
- 1991-01-04 PT PT96421A patent/PT96421B/pt not_active IP Right Cessation
- 1991-01-04 IE IE2091A patent/IE69312B1/en not_active IP Right Cessation
-
1992
- 1992-05-22 FI FI922341A patent/FI922341A/fi not_active Application Discontinuation
-
1995
- 1995-11-01 GR GR950403053T patent/GR3017944T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2067758C (en) | 1994-12-13 |
WO1991010650A1 (en) | 1991-07-25 |
CA2067758A1 (en) | 1991-07-07 |
GB9000301D0 (en) | 1990-03-07 |
FI922341A0 (fi) | 1992-05-22 |
JPH05501560A (ja) | 1993-03-25 |
US5344835A (en) | 1994-09-06 |
IE69312B1 (en) | 1996-09-04 |
DK0510003T3 (da) | 1996-01-29 |
EP0510003B1 (en) | 1995-09-27 |
PT96421A (pt) | 1991-10-15 |
JPH0692365B2 (ja) | 1994-11-16 |
EP0510003A1 (en) | 1992-10-28 |
DE69022744D1 (de) | 1995-11-02 |
GR3017944T3 (en) | 1996-02-29 |
IE910020A1 (en) | 1991-07-17 |
ATE128463T1 (de) | 1995-10-15 |
PT96421B (pt) | 1997-05-28 |
DE69022744T2 (de) | 1996-03-07 |
FI922341A (fi) | 1992-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2078356T3 (es) | Derivados de la pirrolidina y de la piperidina. | |
DE69014901D1 (de) | Muscarin-rezeptor-antagonisten. | |
CA2328780A1 (en) | Dihydropyrimidines | |
ATE188472T1 (de) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
DK0862567T3 (da) | 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister | |
NZ331060A (en) | Quinoxalinediones, preparation and pharmaceutical compositions thereof | |
DE69839753D1 (de) | 2-(Arylphenyl)amino-imidazolin-Derivate | |
EP0335979A4 (en) | Thienopyrimidine derivatives | |
AU4258389A (en) | Muscarinic receptor antagonists | |
NO954538D0 (no) | N-p-halobenzoylmetylderivater av 4-(p-fluorfenyl)-3-((3,4-metylendioksy)fenoksy)metyl)piperidin | |
DE69526097D1 (de) | Bicyclische carboxamide als 5-ht1a rezeptoren liganden | |
KR960007560A (ko) | 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도 | |
EP0798304A4 (en) | DRUGS AGAINST TRHOMBOCYTOPENIA | |
ES2057601T3 (es) | Antagonistas de receptores muscarinicos. | |
NZ304988A (en) | 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives and their use | |
DK0553278T3 (da) | 2-Phenyl- og 2-thienyl-(2)-piperidinderivater med neurobeskyttende egenskaber | |
DE69532187D1 (de) | Abeo-ergolinderivate als 5ht1a liganden | |
DE69217148D1 (de) | Isoxazole derivate als lichtschutzmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 510003 Country of ref document: ES |